Lv21
106 积分 2024-08-16 加入
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
2小时前
已完结
Epigallocatechin gallate inhibits urate crystals‐induced peritoneal inflammation in C57BL/6 mice
2个月前
已完结
Progress and challenges in translating the biology of atherosclerosis
3个月前
已完结
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
3个月前
已完结
Atherosclerosis: current pathogenesis and therapeutic options
3个月前
已完结
Canakinumab for gout: a specific, patient-profiled indication
3个月前
已关闭
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies
3个月前
已完结
皖公网安备34019202002308
